Benoit Marin

researcher

Born 1978-01-01

Benoit Marin is …
instance of (P31):
humanQ5

External links are
P5243Canal-U person IDmarin-benoit-120792397
P269IdRef ID120792397
P213ISNI0000000430795414
P6634LinkedIn personal profile IDpr-benoît-marin-149092b5
P2798Loop ID474198
P496ORCID iD0000-0001-8857-0910
P1053ResearcherIDE-2356-2015
P214VIAF ID172991888

P166award receivedKnight of the National Order of MeritQ13422138
P108employerParis-Sorbonne University - Paris IVQ546118
Assistance Publique – Hôpitaux de ParisQ2867205
P734family nameMarinQ11317591
MarinQ11317591
MarinQ11317591
P735given nameBenoitQ19967779
BenoitQ19967779
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q37221378A prospective hospital study of alcohol use disorders, comorbid psychiatric conditions and withdrawal prognosis
Q36310714A screening questionnaire for convulsive seizures: A three-stage field-validation in rural Bolivia
Q39267570ALS and frontotemporal dementia belong to a common disease spectrum.
Q47847999Accuracy of Teledentistry for Diagnosing Dental Pathology Using Direct Examination as a Gold Standard: Results of the Tel-e-dent Study of Older Adults Living in Nursing Homes.
Q56839377Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients
Q39136111Analgesic interaction between ondansetron and acetaminophen after tonsillectomy in children: the Paratron randomized, controlled trial.
Q40811515Association between mild cognitive impairment and dementia and undernutrition among elderly people in Central Africa: some results from the EPIDEMCA (Epidemiology of Dementia in Central Africa) programme.
Q45006849BMAALS: a French national project searching for a link between amyotrophic lateral sclerosis and the neurotoxic amino acid L-BMAA.
Q51891603Basic critical care echocardiography: validation of a curriculum dedicated to noncardiologist residents.
Q47650805Characteristics and Prognosis of Oldest Old Subjects with Amyotrophic Lateral Sclerosis.
Q38605226Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.
Q56839365Consensus Conference on a Composite Endpoint for Clinical Trials on Immunosuppressive Drugs in Lung Transplantation
Q56839381Contribution of geolocalisation to neuroepidemiological studies: Incidence of ALS and environmental factors in Limousin, France
Q58863039Cytogenetic Studies in Human Cells ExposedIn Vitroto GSM-900 MHz Radiofrequency Radiation Using R-Banded Karyotyping
Q45069595Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
Q38225421Epidemiological evidence that physical activity is not a risk factor for ALS.
Q38685896Epidemiology of amyotrophic lateral sclerosis: A review of literature.
Q33897058Epidemiology of dementia in Central Africa (EPIDEMCA): protocol for a multicentre population-based study in rural and urban areas of the Central African Republic and the Republic of Congo.
Q38907270Epilepsy: Asia versus Africa.
Q42821597Erratum to: Epidemiology of dementia in Central Africa (EPIDEMCA): protocol for a multicentre population-based study in rural and urban areas of the Central African Republic and the Republic of Congo.
Q39215205Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres
Q40564475Experimental pain sensitivity in subjects with major depression: Many pain complaints without hypersensitivity.
Q47815494Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment
Q39371574Extrapyramidal and cognitive signs in amyotrophic lateral sclerosis: A population based cross-sectional study.
Q33868356Feasibility of a cardiovascular cohort in a Sub-Saharan Africa community: preliminary report of the pilot project TAHES (Tanvè Health Study) in Benin
Q37728228Fertility after embolization of the uterine arteries to treat obstetrical hemorrhage: a review of 53 cases.
Q56773792First assessment at home of amyotrophic lateral sclerosis (ALS) patients by a nutrition network in the French region of Limousin
Q38907272First-ever population-based study on status epilepticus in French Island of La Reunion (France) - incidence and fatality
Q40859702Hepatocyte growth factor measurement in AL amyloidosis.
Q41756810Human cytomegalovirus quantification in toddlers saliva from day care centers and emergency unit: a feasibility study.
Q47764699Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis
Q52150386Impact of Continuing First-Line EGFR Tyrosine Kinase Inhibitor Therapy Beyond RECIST Disease Progression in Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer (NSCLC): Retrospective GFPC 04-13 Study.
Q51132286Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997-2007.
Q43293106Incidence of newly diagnosed epileptic seizures in a French South Indian Ocean Island, La Réunion (EPIREUN).
Q46424554Increased CXCL-13 levels in human African trypanosomiasis meningo-encephalitis
Q43716858Intracameral cefuroxime injection at the end of cataract surgery to reduce the incidence of endophthalmitis: French study.
Q38005425Juvenile and adult-onset ALS/MND among Africans: incidence, phenotype, survival: a review
Q58863033Lanreotide autogel 90 mg and lymphorrhea prevention after axillary node dissection in breast cancer: A phase III double blind, randomized, placebo-controlled trial
Q39091509Long-term efficacy of rituximab in IgM anti-myelin-associated glycoprotein neuropathy: RIMAG follow-up study.
Q35577182Magnitude of cardiovascular risk factors in rural and urban areas in Benin: findings from a nationwide steps survey
Q53128482Measurement of the patellar tendon-tibial plateau angle and tuberosity advancement in dogs with cranial cruciate ligament rupture. Reliability of the common tangent and tibial plateau methods of measurement.
Q51173052Newly diagnosed epileptic seizures: focus on an elderly population on the French island of Réunion in the Southern Indian Ocean.
Q58863035Obesity and cervical ripening failure risk
Q46262515Perilesional brain oedema in calcific neurocysticercosis: a target to prevent seizure recurrence?
Q56839400Phase angle is a prognostic factor for survival in amyotrophic lateral sclerosis
Q44787772Physical activity and amyotrophic lateral sclerosis: a European population-based case-control study
Q39215220Population-Based Evidence that Survival in Amyotrophic Lateral Sclerosis is Related to Weight Loss at Diagnosis.
Q39215229Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe--the French register of ALS in Limousin (FRALim register).
Q40144801Prevalence of Multiple Sclerosis in the City of Volta Redonda - Rio De Janeiro, Brazil Using the Capture-Recapture Method
Q33516152Prognosis of ALS: comparing data from the Limousin referral centre, France, and a Uruguayan population.
Q39530443Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP).
Q56839419Qu’est-ce qu’une régression logistique ?
Q58863037Radio-chimiothérapie concomitante chez le sujet âgé indépendant (Essai GFPC 0806 RACCOSA)
Q36086951Randomized Trials in Developing Countries: Different Priorities and Study Design?
Q43828116Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study
Q43706118Reliability of the measurement of the abdominal aortic diameter by novice operators using a pocket-sized ultrasound system
Q28393837Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programme
Q39215197Stratification of ALS patients' survival: a population-based study.
Q36299314Systematic review and meta-analysis estimating association of cysticercosis and neurocysticercosis with epilepsy
Q46197033The value of photodynamic therapy in the treatment of Bowen's disease
Q27010532Toxocariasis and epilepsy: systematic review and meta-analysis
Q44258424Transperineal versus transvaginal ultrasound cervical length measurement and preterm labor.
Q48853046Validation of the use of historical events to estimate the age of subjects aged 65 years and over in Cotonou (Benin).
Q31140078Validity of medico-administrative data related to amyotrophic lateral sclerosis in France: A population-based study
Q33609363Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis
Q39955017Vital and functional outcomes of the first-ever hemispheric stroke, epidemiological comparative study between Kunming (China) and Limoges (France).
Q53502741[Identification of neurodegenerative diseases in administrative databases in France: A systematic review of the literature].
Q46011874[One year follow-up of patients with bullous pemphigoid].
Q43103916mRNA levels of enzymes and receptors implicated in arachidonic acid metabolism in gliomas.
Q48474917rTMS for pharmacoresistant major depression in the clinical setting of a psychiatric hospital: effectiveness and effects of age.
Q56839367Épidémiologie, spectre clinique de la SLA et diagnostics différentiels

Search more.